Growth Metrics

Eli Lilly (LLY) EBITDA Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 183.00
Dec 31, 2025 58.00
Sep 30, 2025 45.00
Jun 30, 2025 375.00
Mar 31, 2025 194.00
Dec 31, 2024 139.00
Sep 30, 2024 382.00
Jun 30, 2024 436.00
Mar 31, 2024 -230.00
Dec 31, 2023 -389.00
Sep 30, 2023 932.00
Jun 30, 2023 377.00
Mar 31, 2023 -546.00
Dec 31, 2022 339.00
Sep 30, 2022 -39.00
Jun 30, 2022 -747.00
Mar 31, 2022 347.00
Dec 31, 2021 -96.00
Sep 30, 2021 894.00
Jun 30, 2021 -10.00
Mar 31, 2021 -1,161.00
Dec 31, 2020 1,090.00
Sep 30, 2020 -389.00
Jun 30, 2020 -188.00
Mar 31, 2020 266.00
Dec 31, 2019 -216.00
Sep 30, 2019 52.00
Jun 30, 2019 334.00
Mar 31, 2019 -155.00
Dec 31, 2018 -145.00
Sep 30, 2018 -186.00
Jun 30, 2018 129.00
Mar 31, 2018 737.00
Dec 31, 2017 -49.00
Sep 30, 2017 -108.00
Jun 30, 2017 130.00
Mar 31, 2017 187.00
Dec 31, 2016 -76.00
Sep 30, 2016 89.00
Jun 30, 2016 74.00
Mar 31, 2016 358.00
Dec 31, 2015 -640.00
Sep 30, 2015 105.00
Jun 30, 2015 5.00
Mar 31, 2015 191.00
Dec 31, 2014 301.00
Sep 30, 2014 -374.00
Jun 30, 2014 -53.00
Mar 31, 2014 140.00
Dec 31, 2013 -966.00
Sep 30, 2013 34.00
Jun 30, 2013 65.00
Mar 31, 2013 448.00
Dec 31, 2012 36.00
Sep 30, 2012 -53.00
Jun 30, 2012 -362.00
Mar 31, 2012 741.00
Dec 31, 2011 -812.00
Sep 30, 2011 38.00
Jun 30, 2011 -324.00
Mar 31, 2011 523.00
Dec 31, 2010 -437.00
Sep 30, 2010 -75.00
Jun 30, 2010 -214.00
Mar 31, 2010 886.00
Dec 31, 2009 400.00
Sep 30, 2009 -1,036.00
Jun 30, 2009 -657.00